Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks

BACKGROUND: Therapies available for late stage prostate cancer (PCa) patients are limited and mostly palliative. The necessary development of unexplored therapeutic options relies on a deeper knowledge of molecular mechanisms leading to cancer progression. Redox signals are known to modulate the int...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelius, Julian, Cavarretta, Ilaria, Pozzi, Edoardo, Lavorgna, Giovanni, Locatelli, Irene, Tempio, Tiziana, Montorsi, Francesco, Mattei, Agostino, Sitia, Roberto, Salonia, Andrea, Anelli, Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039598/
https://www.ncbi.nlm.nih.gov/pubmed/33850746
http://dx.doi.org/10.21037/tau-20-1025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039598/
https://www.ncbi.nlm.nih.gov/pubmed/33850746
http://dx.doi.org/10.21037/tau-20-1025

Ejemplares similares